A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study
Clinical trial NCT02218008 · COMPLETED
Trial details
- NCT number
- NCT02218008
- Sponsor
- Alkermes, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2016-09-01
- Enrollment
- 407
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.